In breast and epithelial ovarian cancers, the overexpression of p53R2 is correlated with the tumor grade, and this subunit is also highly expressed in malignant melanoma relative to benign skin lesions [58,59,60]. This evidence concerns the gene RRM2B and neoplasm.